NCT04170504View on ClinicalTrials.gov

Efficacy of Chinese Herbal Medicine Qing Re Huo Xue in Patients With Rheumatoid Arthritis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

204

Participants

Timeline

Start Date

November 14, 2019

Primary Completion Date

June 28, 2022

Study Completion Date

June 28, 2022

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Qing Re Huo Xue (QRHX) granule

Qing Re Huo Xue (QRHX) granule 10g bid for 24 weeks

DRUG

Methotrexate

Oral methotrexate 10 mg per week for 24 weeks.

DRUG

Qing Re Huo Xue (QRHX) granule placebo

Qing Re Huo Xue (QRHX) granule placebo 10g bid for 24 weeks

Trial Locations (1)

100053

Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing

All Listed Sponsors
lead

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

OTHER

NCT04170504 - Efficacy of Chinese Herbal Medicine Qing Re Huo Xue in Patients With Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter